22 Jul Angiocrine Bioscience
Paul Finnegan, M.D., CEO
Oct. 12 | 1:30pm | BlueRock Therapeutics Ballroom
San Diego, CA
Angiocrine Bioscience aims to transform medicine by harnessing the natural powers of endothelial cells to enable the repair of tissues and organs for patients with life-threatening and debilitating conditions through its proprietary, genetically engineered, E-CEL technology platform.